$SYNA
SYNAPTICS Inc Stock $syna

$syna Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000095017022017628 Filed on August 22, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$448.1M	$476.4M	$1.740B
YoY Change	20.23%	45.33%	29.87%
Cost Of Revenue	$192.4M	$210.3M	$796.6M
YoY Change	10.19%	33.95%	9.36%
Gross Profit	$255.7M	$266.1M	$943.1M
YoY Change	29.08%	55.8%	54.3%
Gross Profit Margin	57.06%	55.86%	54.21%
Selling, General & Admin	$44.70M	$38.30M	$168.4M
YoY Change	7.45%	15.02%	16.22%
% of Gross Profit	17.48%	14.39%	17.86%
Research & Development	$89.50M	$94.10M	$367.3M
YoY Change	3.95%	21.11%	17.2%
% of Gross Profit	35.0%	35.36%	38.95%
Depreciation & Amortization	$41.90M	$9.100M	$38.70M
YoY Change	37.83%	-71.29%	-70.62%
% of Gross Profit	16.39%	3.42%	4.1%
Operating Expenses	$143.7M	$141.5M	$592.7M
YoY Change	4.51%	18.31%	27.68%
Operating Profit	$112.0M	$124.6M	$350.4M
YoY Change	84.82%	143.36%	138.37%
Interest Expense	$6.900M	-$8.900M	$30.20M
YoY Change	-216.95%	0.0%	2.37%
% of Operating Profit	6.16%	-7.14%	8.62%
Other Income/Expense, Net	-$8.300M	$3.000M	$1.300M
YoY Change	40.68%
Pretax Income	$103.7M	$115.2M	$320.5M
YoY Change	122.53%	176.26%	166.86%
Income Tax	$39.10M	$32.30M	$64.60M
% Of Pretax Income	37.7%	28.04%	20.16%
Net Earnings	$64.60M	$82.90M	$257.5M
YoY Change	60.7%	336.32%	223.49%
Net Earnings / Revenue	14.42%	17.4%	14.8%
Basic Earnings Per Share	$1.62		$6.60
Diluted Earnings Per Share	$1.59	$2.042M	$6.33
COMMON SHARES
Basic Shares Outstanding	39.63M	39.61M	39.00M
Diluted Shares Outstanding	40.70		40.70M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$911.8M	$876.0M	$876.0M
YoY Change	162.54%	4.75%	4.75%
Cash & Equivalents	$867.8M	$824.0M	$824.0M
Short-Term Investments	$44.00M	$52.00M	$52.00M
Other Short-Term Assets	$36.50M	$35.60M	$35.60M
YoY Change	-16.48%	7.55%	7.55%
Inventory	$179.4M	$169.7M	$169.7M
Prepaid Expenses
Receivables	$284.1M	$322.1M	$322.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.412B	$1.403B	$1.403B
YoY Change	88.39%	18.96%	18.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$63.40M	$62.90M	$62.90M
YoY Change	-31.16%	-31.03%	-48.82%
Goodwill	$806.6M	$806.6M
YoY Change	41.51%	41.51%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$128.0M	$134.0M	$195.2M
YoY Change	35.59%	154.27%	270.4%
Total Long-Term Assets	$1.413B	$1.455B	$1.455B
YoY Change	36.81%	38.93%	38.93%
TOTAL ASSETS
Total Short-Term Assets	$1.412B	$1.403B	$1.403B
Total Long-Term Assets	$1.413B	$1.455B	$1.455B
Total Assets	$2.825B	$2.858B	$2.858B
YoY Change	58.5%	28.35%	28.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$125.0M	$141.8M	$141.8M
YoY Change	13.95%	45.29%	45.29%
Accrued Expenses	$128.2M	$235.9M	$235.9M
YoY Change	-27.08%	36.67%	36.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.000M	$6.000M	$6.000M
YoY Change		-98.77%	-98.77%
Total Short-Term Liabilities	$365.3M	$463.4M	$463.4M
YoY Change	20.36%	-41.1%	-41.1%
LONG-TERM LIABILITIES
Long-Term Debt	$974.8M	$975.7M	$975.7M
YoY Change	147.1%	147.39%	147.39%
Other Long-Term Liabilities	$159.6M	$152.6M	$152.6M
YoY Change	92.75%	94.39%	196.89%
Total Long-Term Liabilities	$1.134B	$1.128B	$1.128B
YoY Change	137.67%	138.59%	153.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$365.3M	$463.4M	$463.4M
Total Long-Term Liabilities	$1.134B	$1.128B	$1.128B
Total Liabilities	$1.500B	$1.592B	$1.592B
YoY Change	92.07%	26.37%	26.37%
SHAREHOLDERS EQUITY
Retained Earnings	$1.103B	$1.039B
YoY Change	34.33%	32.97%
Common Stock	$931.8M	$924.2M
YoY Change	6.53%	-33.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$707.9M	$694.5M
YoY Change	1.93%	-42.38%
Treasury Stock Shares
Shareholders Equity	$1.325B	$1.266B	$1.266B
YoY Change
Total Liabilities & Shareholders Equity	$2.825B	$2.858B	$2.858B
YoY Change	58.5%	28.35%	28.35%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	$64.60M	$82.90M	$257.5M
YoY Change	60.7%	336.32%	223.49%
Depreciation, Depletion And Amortization	$41.90M	$9.100M	$38.70M
YoY Change	37.83%	-71.29%	-70.62%
Cash From Operating Activities	$78.50M	$128.0M	$462.7M
YoY Change	34.65%	22.02%	44.96%
INVESTING ACTIVITIES
Capital Expenditures	$6.200M	-$4.200M	$31.10M
YoY Change	31.91%	-25.0%	47.39%
Acquisitions			$501.1M
YoY Change			-20.02%
Other Investing Activities	$8.500M	$17.20M	-$425.3M
YoY Change			-15.19%
Cash From Investing Activities	$2.300M	$13.00M	-$482.7M
YoY Change	-148.94%	-332.14%	-7.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-35.00M	-2.600M	14.30M
YoY Change	-93.54%	-86.93%	-94.78%
NET CHANGE
Cash From Operating Activities	78.50M	128.0M	462.7M
Cash From Investing Activities	2.300M	13.00M	-482.7M
Cash From Financing Activities	-35.00M	-2.600M	14.30M
Net Change In Cash	43.80M	138.4M	-12.30M
YoY Change	-108.96%	74.31%	-116.87%
FREE CASH FLOW
Cash From Operating Activities	$78.50M	$128.0M	$462.7M
Capital Expenditures	$6.200M	-$4.200M	$31.10M
Free Cash Flow	$72.30M	$132.2M	$431.6M
YoY Change	34.89%	19.64%	44.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#Liabilities
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-26
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000817720
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2022	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2025-07-31
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#Liabilities
CY2022Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#Liabilities
CY2021Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#Liabilities
CY2021	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-25
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-49602
CY2022	dei	Entity Registrant Name EntityRegistrantName	SYNAPTICS INCORPORATED
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0118518
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1109 McKay Drive
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95131
CY2022	dei	City Area Code CityAreaCode	(408
CY2022	dei	Local Phone Number LocalPhoneNumber	904-1100
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
CY2022	dei	Trading Symbol TradingSymbol	SYNA
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	7188751584000000
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39634112
CY2022	dei	Auditor Name AuditorName	KPMG LLP
CY2022	dei	Auditor Location AuditorLocation	Santa Clara, California
CY2022	dei	Auditor Firm AuditorFirmId	185
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	824000000.0
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	836300000
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	52000000.0
CY2021Q2	us-gaap	Short Term Investments ShortTermInvestments	0
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6000000.0
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5800000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	322100000
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	228300000
CY2022Q2	us-gaap	Inventory Net InventoryNet	169700000
CY2021Q2	us-gaap	Inventory Net InventoryNet	82000000.0
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35600000
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	33100000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1403400000
CY2021Q2	us-gaap	Assets Current AssetsCurrent	1179700000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62900000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	91200000
CY2022Q2	us-gaap	Goodwill Goodwill	806600000
CY2021Q2	us-gaap	Goodwill Goodwill	570000000.0
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	390000000.0
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	301500000
CY2022Q2	syna	Right Of Use Assets RightOfUseAssets	61200000
CY2021Q2	syna	Right Of Use Assets RightOfUseAssets	31700000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	134000000.0
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	52700000
CY2022Q2	us-gaap	Assets Assets	2858100000
CY2021Q2	us-gaap	Assets Assets	2226800000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	141800000
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	97600000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	90600000
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	76400000
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	79700000
CY2021Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	29400000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	145300000
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	96200000
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000.0
CY2021Q2	syna	Convertible Notes Payable Net ConvertibleNotesPayableNet	487100000
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67745800
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66963006
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39621179
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35331903
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	100000
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	100000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	463400000
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	786700000
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	975700000
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	394400000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	152600000
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	78500000
CY2022Q2	us-gaap	Liabilities Liabilities	1591700000
CY2021Q2	us-gaap	Liabilities Liabilities	1259600000
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	924100000
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1391500000
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	28124621
CY2021Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	31631103
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	694500000
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1205400000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1800000
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1038500000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	781000000.0
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1266400000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	967200000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2858100000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2226800000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1739700000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1339600000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1333900000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	796600000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	728400000
CY2022	us-gaap	Interest Income Other InterestIncomeOther	3000000.0
CY2021	us-gaap	Interest Income Other InterestIncomeOther	2900000
CY2020	us-gaap	Interest Income Other InterestIncomeOther	7900000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	790800000
CY2022	us-gaap	Gross Profit GrossProfit	943100000
CY2021	us-gaap	Gross Profit GrossProfit	611200000
CY2020	us-gaap	Gross Profit GrossProfit	543100000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	367300000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	313400000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	302500000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	168400000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	144900000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	127000000.0
CY2022	syna	Amortization Of Intangible Assets Included In Operating Expense AmortizationOfIntangibleAssetsIncludedInOperatingExpense	38700000
CY2021	syna	Amortization Of Intangible Assets Included In Operating Expense AmortizationOfIntangibleAssetsIncludedInOperatingExpense	32700000
CY2020	syna	Amortization Of Intangible Assets Included In Operating Expense AmortizationOfIntangibleAssetsIncludedInOperatingExpense	11700000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	18300000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	7400000
CY2020	us-gaap	Restructuring Charges RestructuringCharges	33000000.0
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	34200000
CY2020	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0
CY2022	us-gaap	Operating Expenses OperatingExpenses	592700000
CY2021	us-gaap	Operating Expenses OperatingExpenses	464200000
CY2020	us-gaap	Operating Expenses OperatingExpenses	474200000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	350400000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	147000000.0
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	68900000
CY2022	us-gaap	Interest Expense InterestExpense	30200000
CY2021	us-gaap	Interest Expense InterestExpense	29500000
CY2020	us-gaap	Interest Expense InterestExpense	22500000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8100000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-300000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2022	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	5400000
CY2021	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0
CY2020	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0
CY2021	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0
CY2020	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	105100000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	320500000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	120100000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	159400000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64600000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31400000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38600000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1600000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9100000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2000000.0
CY2022	us-gaap	Net Income Loss NetIncomeLoss	257500000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	79600000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	118800000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.60
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.29
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.54
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.33
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.08
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.41
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39000000.0
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34800000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33600000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40700000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38300000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34800000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	257500000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	79600000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	118800000
CY2022	syna	Other Comprehensive Income Loss Unrealized Available For Sale Securities OtherComprehensiveIncomeLossUnrealizedAvailableForSaleSecurities	1800000
CY2021	syna	Other Comprehensive Income Loss Unrealized Available For Sale Securities OtherComprehensiveIncomeLossUnrealizedAvailableForSaleSecurities	0
CY2020	syna	Other Comprehensive Income Loss Unrealized Available For Sale Securities OtherComprehensiveIncomeLossUnrealizedAvailableForSaleSecurities	0
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	255700000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	79600000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	118800000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	656400000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	118800000
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	34500000
CY2020	syna	Payroll Taxes For Deferred Stock Units PayrollTaxesForDeferredStockUnits	9700000
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	30200000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	49300000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	819100000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	79600000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27800000
CY2021	syna	Payroll Taxes For Deferred Stock Units PayrollTaxesForDeferredStockUnits	300000
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	28300000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	69300000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	967200000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	257500000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1800000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15200000
CY2022	syna	Issuance Of Treasury Stock For Redemption Of Convertible Notes IssuanceOfTreasuryStockForRedemptionOfConvertibleNotes	6900000
CY2022	syna	Payroll Taxes For Deferred Stock Units PayrollTaxesForDeferredStockUnits	67300000
CY2022	syna	Share Based Compensation Attributable To Acquisition ShareBasedCompensationAttributableToAcquisition	1700000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	100800000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1266400000
CY2022	us-gaap	Profit Loss ProfitLoss	257500000
CY2021	us-gaap	Profit Loss ProfitLoss	79600000
CY2020	us-gaap	Profit Loss ProfitLoss	118800000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	100800000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	66100000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	49300000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24000000.0
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21600000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26700000
CY2022	syna	Acquired Intangibles Amortization AcquiredIntangiblesAmortization	123500000
CY2021	syna	Acquired Intangibles Amortization AcquiredIntangiblesAmortization	110100000
CY2020	syna	Acquired Intangibles Amortization AcquiredIntangiblesAmortization	51400000
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	34200000
CY2020	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0
CY2021	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0
CY2020	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	105100000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5400000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1200000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8100000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-300000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	29700000
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	5200000
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-2700000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1600000
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	19200000
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18300000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1800000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	600000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	600000
CY2022	syna	Amortization Of Cost Of Development Services AmortizationOfCostOfDevelopmentServices	10000000.0
CY2021	syna	Amortization Of Cost Of Development Services AmortizationOfCostOfDevelopmentServices	9200000
CY2020	syna	Amortization Of Cost Of Development Services AmortizationOfCostOfDevelopmentServices	0
CY2022	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	2400000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1600000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9100000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2000000.0
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1300000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3700000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7600000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2800000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-400000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	81100000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25900000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-31000000.0
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	65100000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-53100000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-43000000.0
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6900000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9400000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2900000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-25800000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3900000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	23200000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	32200000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-36200000
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5300000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	14900000
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	29100000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	48600000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2100000
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	13800000
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	17400000
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-17200000
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-29900000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	462700000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	319200000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	221800000
CY2022	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	55900000
CY2021	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0
CY2020	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	138700000
CY2022	syna	Payment To Acquire In Process Research And Development PaymentToAcquireInProcessResearchAndDevelopment	0
CY2021	syna	Payment To Acquire In Process Research And Development PaymentToAcquireInProcessResearchAndDevelopment	0
CY2020	syna	Payment To Acquire In Process Research And Development PaymentToAcquireInProcessResearchAndDevelopment	2500000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	501100000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	626500000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	30000000.0
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0
CY2022	syna	Proceeds From Sale Of Audio Technology Assets ProceedsFromSaleOfAudioTechnologyAssets	0
CY2021	syna	Proceeds From Sale Of Audio Technology Assets ProceedsFromSaleOfAudioTechnologyAssets	34200000
CY2020	syna	Proceeds From Sale Of Audio Technology Assets ProceedsFromSaleOfAudioTechnologyAssets	0
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	24400000
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	95800000
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0
CY2022	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	-5800000
CY2021	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	0
CY2020	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	0
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31100000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21100000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16300000
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	5000000.0
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0
CY2022	syna	Payment For Cost Method Investment PaymentForCostMethodInvestment	0
CY2021	syna	Payment For Cost Method Investment PaymentForCostMethodInvestment	5000000.0
CY2020	syna	Payment For Cost Method Investment PaymentForCostMethodInvestment	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-482700000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-522600000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	119900000
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	600000000.0
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	400000000.0
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000000.0
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3000000.0
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	100000000.0
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	30200000
CY2022	syna	Refundable Deposit Paid To Vendor RefundableDepositPaidToVendor	-16600000
CY2021	syna	Refundable Deposit Paid To Vendor RefundableDepositPaidToVendor	0
CY2020	syna	Refundable Deposit Paid To Vendor RefundableDepositPaidToVendor	0
CY2022	syna	Return Of Deposit Received From Vendor ReturnOfDepositReceivedFromVendor	2800000
CY2021	syna	Return Of Deposit Received From Vendor ReturnOfDepositReceivedFromVendor	0
CY2020	syna	Return Of Deposit Received From Vendor ReturnOfDepositReceivedFromVendor	0
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	15200000
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	27800000
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	34500000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11200000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6100000
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	700000
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	505600000
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	19400000
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0
CY2022	syna	Payment For Payroll Taxes For Deferred Stock And Market Stock Units PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits	67300000
CY2021	syna	Payment For Payroll Taxes For Deferred Stock And Market Stock Units PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits	28200000
CY2020	syna	Payment For Payroll Taxes For Deferred Stock And Market Stock Units PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits	9700000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14300000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	274100000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	93900000
CY2022	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-6600000
CY2021	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2200000
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12300000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	72900000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	435600000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	836300000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	763400000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	327800000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	824000000.0
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	836300000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	763400000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	25000000.0
CY2021	us-gaap	Interest Paid Net InterestPaidNet	9600000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	3700000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	42000000.0
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	39700000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	18900000
CY2022	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	3700000
CY2021	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	300000
CY2020	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1300000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3600000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	800000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1200000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue, allowance for doubtful accounts, cost of revenue, inventories, loss on purchase commitments, product warranty, accrued liabilities, share-based compensation costs, provision for income taxes, deferred income tax asset valuation allowances, uncertain tax positions, goodwill, intangible assets, investments, and loss contingencies. We base our estimates on historical experience, applicable laws and regulations, and various other assumptions that we believe to be reasonable under the circumstances, including our expectations regarding the potential impacts on our business of the COVID-19 pandemic, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></p>
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	824000000.0
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	836300000
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, investments, and accounts receivable. Our investment policy, which is predicated on capital preservation and liquidity, limits investments to U.S. government treasuries and agency issues, taxable securities, and municipal issued securities with a minimum rating of investment grade by the rating agencies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">We sell our products to contract manufacturers that provide manufacturing services for OEMs, to some OEMs directly, and to distributors. We extend credit based on an evaluation of a customer’s financial condition, and we generally do not require collateral.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following customers accounted for more than 10% of our accounts receivable balance as of the end of fiscal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2022 and 2021:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.998%;"/> <td style="width:1.62%;"/> <td style="width:14.881%;"/> <td style="width:1.62%;"/> <td style="width:14.881%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Customer A</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Customer B</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> </table></div>
CY2022	us-gaap	Revenue Performance Obligation Description Of Payment Terms RevenuePerformanceObligationDescriptionOfPaymentTerms	Payments are generally due within three months of completion of the performance obligation and subsequent invoicing and, therefore, do not include significant financing components.
CY2021	syna	Account Receivable Bad Debt Charge AccountReceivableBadDebtCharge	0
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1200000
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1900000
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	27300000
CY2022Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	61300000
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7000000.0
CY2021Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	36100000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3600000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1800000
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	720100000
CY2022	syna	Account Receivable Bad Debt Charge AccountReceivableBadDebtCharge	200000
CY2022Q2	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	92200000
CY2021Q2	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	49100000
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	77500000
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	32900000
CY2022Q2	us-gaap	Inventory Net InventoryNet	169700000
CY2021Q2	us-gaap	Inventory Net InventoryNet	82000000.0
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	330100000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	390000000.0
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	544700000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	243200000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	301500000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	123500000
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	5000000.0
CY2022	syna	Gain On Sale Of Investment GainOnSaleOfInvestment	2500000
CY2022	syna	Net Loss Offset NetLossOffset	900000
CY2022	syna	Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax	5600000
CY2020	syna	Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax	200000
CY2021	syna	Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax	-1400000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3500000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	110100000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51400000
CY2022Q2	syna	Customer Obligation CustomerObligation	88600000
CY2021Q2	syna	Customer Obligation CustomerObligation	43100000
CY2022Q2	syna	Accrued Liabilities For Inventory Purchase AccruedLiabilitiesForInventoryPurchase	14100000
CY2021Q2	syna	Accrued Liabilities For Inventory Purchase AccruedLiabilitiesForInventoryPurchase	17000000.0
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7600000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9300000
CY2022Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	35000000.0
CY2021Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	26800000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	145300000
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	96200000
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1200000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40700000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38300000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34800000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.60
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.29
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.54
CY2022Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	29100000
CY2021Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	15400000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	52600000
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	27100000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51500000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24000000.0
CY2022Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	19400000
CY2021Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	12000000.0
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	152600000
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	78500000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.33
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.08
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.41
CY2022Q2	us-gaap	Goodwill Goodwill	806600000
CY2021Q2	us-gaap	Goodwill Goodwill	570000000.0
CY2022	us-gaap	Net Income Loss NetIncomeLoss	257500000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	79600000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	118800000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39000000.0
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34800000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33600000
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1700000
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	185700000
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	222200000
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	122800000
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	131000000.0
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62900000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	91200000
CY2022	syna	Allocation Of Stock Based Compensation Replacement Awards AllocationOfStockBasedCompensationReplacementAwards	1700000
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	52000000.0
CY2022Q2	syna	Cash Held In Bank CashHeldInBank	811900000
CY2021Q2	us-gaap	Goodwill Goodwill	570000000.0
CY2020Q2	us-gaap	Goodwill Goodwill	360800000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	236600000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	209200000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	127500000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	66900000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	60000000.0
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	47000000.0
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	16600000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5000000.0
CY2022Q2	syna	Finite Lived Intangible Assets Amortization Expense To Be Determined FiniteLivedIntangibleAssetsAmortizationExpenseToBeDetermined	67000000.0
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	390000000.0
CY2022	syna	Redemption Of Principal Amout Percentage RedemptionOfPrincipalAmoutPercentage	1
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5700000
CY2022	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	16600000
CY2022	syna	Percentage Of Voting Capital Stock Of Certain Foreign Subsidiaries Collateralized PercentageOfVotingCapitalStockOfCertainForeignSubsidiariesCollateralized	0.65
CY2022	syna	Percentage Of Non Voting Capital Stock PercentageOfNonVotingCapitalStock	1
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	600000000.0
CY2021Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2028-12-02
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11200000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9200000
CY2022	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	The leases expire at various dates through fiscal year 2034, some of which include options to extend the lease for up to seven years.
CY2022	syna	Lease Expiration Year LeaseExpirationYear	2034
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	12700000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12500000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	59100000
CY2022	syna	Rent Expense Recognized RentExpenseRecognized	12700000
CY2021	syna	Rent Expense Recognized RentExpenseRecognized	10100000
CY2022	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	5400000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61200000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31700000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7600000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9300000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51500000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24000000.0
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	59100000
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	33300000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	12500000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	10000000.0
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	42500000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	21800000
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y7D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0414
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6300000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10300000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9000000.0
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	8300000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	28500000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	71600000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4449604
CY2022Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6394711
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1800000000
CY2022Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	577400000
CY2022	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	3500000
CY2021	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	100000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3381840
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	2000000
CY2022	syna	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Restricted Stock Units Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsGrantsInPeriod	641690
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	65000
CY2022	syna	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Performance Stock Units Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceStockUnitsGrantsInPeriod	96914
CY2022	syna	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Adjustments For Performance Stock Units ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsForPerformanceStockUnits	-133627
CY2022	syna	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Adjustments For Performance Results Attained ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsForPerformanceResultsAttained	-69728
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	138502
CY2022	syna	Share Based Compensation Arrangement By Share Based Payment Awards Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeituresInPeriod	337171
CY2022	syna	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Unavailable For Grant Upon Expiration Of Plan ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnavailableForGrantUponExpirationOfPlan	-123946
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4449604
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	100900000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	93100000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	60400000
CY2022	syna	Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense	23100000
CY2021	syna	Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense	15200000
CY2020	syna	Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense	6300000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	55061
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	66.68
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	23876
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	73.44
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31185
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	61.50
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2100000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	31185
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	61.50
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2100000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5300000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23900000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23900000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3600000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8600000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10800000
CY2022	syna	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Performance Adjustment ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustment	183472
CY2022	syna	Stock Purchases Under Employee Stock Purchase Plan As Compensation Maximum Subject To Legal Restrictions And Limitations StockPurchasesUnderEmployeeStockPurchasePlanAsCompensationMaximumSubjectToLegalRestrictionsAndLimitations	0.15
CY2022	syna	Employee Common Stock Purchases Through Payroll Deductions Under Employee Stock Purchase Plan Price As Percentage Of Fair Market Value EmployeeCommonStockPurchasesThroughPayrollDeductionsUnderEmployeeStockPurchasePlanPriceAsPercentageOfFairMarketValue	0.85
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	20500
CY2022	syna	Defined Contribution Plans Eligible Employee Contributions Employees Fifty And Over Annual Limit DefinedContributionPlansEligibleEmployeeContributionsEmployeesFiftyAndOverAnnualLimit	27000
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.25
CY2022	syna	Contributions By Employer Matching Contributions ContributionsByEmployerMatchingContributions	1700000
CY2021	syna	Contributions By Employer Matching Contributions ContributionsByEmployerMatchingContributions	1800000
CY2020	syna	Contributions By Employer Matching Contributions ContributionsByEmployerMatchingContributions	2100000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	100000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	7900000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	5200000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	3000000.0
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	320500000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	120100000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	159400000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-600000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4100000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	800000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	100000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	94900000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	36100000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	35400000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	94300000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	40300000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	36200000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-21800000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-500000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5800000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	100000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-7900000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-8400000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	8100000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-29700000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8900000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2400000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64600000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31400000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38600000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	67300000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	25100000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	33500000
CY2022	syna	Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount	18100000
CY2021	syna	Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount	3800000
CY2020	syna	Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount	-2100000
CY2022	syna	Income Tax Reconciliation Non Deductible Compensation IncomeTaxReconciliationNonDeductibleCompensation	6400000
CY2021	syna	Income Tax Reconciliation Non Deductible Compensation IncomeTaxReconciliationNonDeductibleCompensation	6400000
CY2020	syna	Income Tax Reconciliation Non Deductible Compensation IncomeTaxReconciliationNonDeductibleCompensation	1900000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	10000000.0
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	3800000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	6100000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	6400000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-6700000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	4900000
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	3600000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	5200000
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	700000
CY2022	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	700000
CY2021	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	3500000
CY2020	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	0
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	400000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	200000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1400000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64600000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31400000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38600000
CY2022Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	17800000
CY2021Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	200000
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2600000
CY2021Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	3900000
CY2022Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	11700000
CY2021Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	6000000.0
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12000000.0
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8800000
CY2022Q2	syna	Nondeductible Interest NondeductibleInterest	5400000
CY2021Q2	syna	Nondeductible Interest NondeductibleInterest	0
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	62000000.0
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	39100000
CY2022Q2	syna	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	11200000
CY2021Q2	syna	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	6500000
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16300000
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7200000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5600000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5100000
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	144600000
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	76800000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	59000000.0
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32600000
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	85600000
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	44200000
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2000000.0
CY2021Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	900000
CY2022Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Interest DeferredTaxLiabilitiesDeferredExpenseCapitalizedInterest	0
CY2021Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Interest DeferredTaxLiabilitiesDeferredExpenseCapitalizedInterest	3400000
CY2022Q2	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	11500000
CY2021Q2	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	6200000
CY2022Q2	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	22100000
CY2021Q2	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	3500000
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	45800000
CY2021Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	29000000.0
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	81400000
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	43000000.0
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4200000
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1200000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	59000000.0
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	26400000
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	17900000
CY2022Q2	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability	200000000
CY2022Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	46000000
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	7200000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22600000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	29800000
CY2021Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	19600000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22600000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20100000
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18900000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	7100000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5500000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3200000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	5500000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	100000
CY2022	syna	Unrecognized Tax Benefits Decreases Resulting From Remeasurement UnrecognizedTaxBenefitsDecreasesResultingFromRemeasurement	-500000
CY2021	syna	Unrecognized Tax Benefits Decreases Resulting From Remeasurement UnrecognizedTaxBenefitsDecreasesResultingFromRemeasurement	0
CY2020	syna	Unrecognized Tax Benefits Decreases Resulting From Remeasurement UnrecognizedTaxBenefitsDecreasesResultingFromRemeasurement	0
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	4900000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	3000000.0
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2100000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	29800000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22600000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20100000
CY2022	syna	Increase Decrease In Unrecognized Tax Benefit Income Tax Penalties And Interest Accrued IncreaseDecreaseInUnrecognizedTaxBenefitIncomeTaxPenaltiesAndInterestAccrued	800000
CY2021	syna	Increase Decrease In Unrecognized Tax Benefit Income Tax Penalties And Interest Accrued IncreaseDecreaseInUnrecognizedTaxBenefitIncomeTaxPenaltiesAndInterestAccrued	200000
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2500000
CY2021Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1700000
CY2022Q2	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	900000
CY2022Q2	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	6900000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	syna	Number Of Product Categories NumberOfProductCategories	3
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1739700000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1339600000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1333900000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1739700000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1339600000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1333900000
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	1259500000
CY2021Q2	us-gaap	Noncurrent Assets NoncurrentAssets	962700000
CY2021Q2	us-gaap	Restructuring Reserve RestructuringReserve	200000
CY2020Q2	us-gaap	Restructuring Reserve RestructuringReserve	6100000
CY2019Q2	us-gaap	Restructuring Reserve RestructuringReserve	5200000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	18300000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	7400000
CY2020	us-gaap	Restructuring Charges RestructuringCharges	33000000.0
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	17100000
CY2021	us-gaap	Payments For Restructuring PaymentsForRestructuring	13300000
CY2020	us-gaap	Payments For Restructuring PaymentsForRestructuring	32100000
CY2022Q2	us-gaap	Restructuring Reserve RestructuringReserve	1400000
CY2021Q2	us-gaap	Restructuring Reserve RestructuringReserve	200000
CY2020Q2	us-gaap	Restructuring Reserve RestructuringReserve	6100000
CY2022	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	18300000
CY2021	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	7400000

Files In Submission

Name	View Source	Status
0000950170-22-017628-index-headers.html	Edgar Link	pending
0000950170-22-017628-index.html	Edgar Link	pending
0000950170-22-017628.txt	Edgar Link	pending
0000950170-22-017628-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img256028027_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
syna-20220625.htm	Edgar Link	pending
syna-20220625.xsd	Edgar Link	pending
syna-ex10_3.htm	Edgar Link	pending
syna-ex21.htm	Edgar Link	pending
syna-ex23_1.htm	Edgar Link	pending
syna-ex31_1.htm	Edgar Link	pending
syna-ex31_2.htm	Edgar Link	pending
syna-ex32_1.htm	Edgar Link	pending
syna-ex32_2.htm	Edgar Link	pending
syna-20220625_lab.xml	Edgar Link	unprocessable
syna-20220625_def.xml	Edgar Link	unprocessable
syna-20220625_pre.xml	Edgar Link	unprocessable
syna-20220625_htm.xml	Edgar Link	completed
syna-20220625_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SYNA
SYNAPTICS Inc Stock $syna

2022 Q3 Form 10-K Financial Statement

#000095017022017628 Filed on August 22, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SYNA SYNAPTICS Inc Stock $syna

2022 Q3 Form 10-K Financial Statement

#000095017022017628 Filed on August 22, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SYNA
SYNAPTICS Inc Stock $syna